⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17348242 | 1.00 | — | — | |
| SCHEMBL8273624 | 0.84 | — | — | |
| SCHEMBL10187340 | 0.84 | — | — | |
| SCHEMBL19058221 | 0.83 | — | — | |
| SCHEMBL12296164 | 0.83 | ESR1 (0.38) | — | |
| SCHEMBL19143895 | 0.83 | — | — | |
| SCHEMBL24270373 | 0.81 | — | — | |
| SCHEMBL12068011 | 0.81 | — | — | |
| SCHEMBL18799154 | 0.75 | — | — | |
| SCHEMBL16976231 | 0.72 | PLG (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127266-A1 | MALIC ENZYME INHIBITORS | SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) | 2022-04-28 | — | — | US | disclosed |
| EP-2906539-B1 | INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES | HIVIH (FR) | 2017-06-21 | — | — | EP | disclosed |
| WO-2013064543-A1 | PHARMACEUTICAL COMPOUNDS | ASTEX THERAPEUTICS LIMITED (GB) | 2013-05-10 | — | — | WO | disclosed |
| EP-2342191-B1 | AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE | MITSUBISHI TANABE PHARMA CORP (JP) | 2013-03-20 | — | — | EP | disclosed |
| WO-2012168226-A1 | DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2012-12-13 | — | — | WO | disclosed |
| US-20120114943-A1 | CROSSLINKING SYSTEMS FOR HYDROXYL POLYMERS | HEINZMAN STEPHEN WAYNE (US) | 2012-05-10 | — | — | US | disclosed |
| US-8129449-B2 | Crosslinking systems for hydroxyl polymers | THE PROCTER & GABMLE COMPANY (US) | 2012-03-06 | — | — | US | disclosed |
| US-8088843-B2 | Crosslinking systems for hydroxyl polymers | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-03 | — | — | US | disclosed |
| US-20110263113-A1 | METHOD FOR MANUFACTURING A SEMICONDUCTOR DEVICE | RENESAS ELECTRONICS CORPORATION (JP) | 2011-10-27 | — | — | US | disclosed |
| EP-1237891-B1 | HETEROCYCLIC DIHYDROPYRIMIDINES AS POTASSIUM CHANNEL INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2011-09-28 | — | — | EP | disclosed |
| EP-1389110-B1 | INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND METHODS FOR IDENTIFYING THE SAME | AVANIR PHARMACEUTICALS (US) | 2010-03-24 | — | — | EP | disclosed |
| WO-2010021680-A2 | INHIBITORS OF BETA-SECRETASE | VITAE PHARMACEUTICALS, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-1011545-B1 | RESORBABLE INTERBODY SPINAL FUSION DEVICES | DEPUY MITEK INC (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20090095997-A1 | EPITAXIAL SILICON GROWTH | MICRON TECHNOLOGY, INC. (US) | 2009-04-16 | — | — | US | disclosed |
| WO-2008060476-A2 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | SCHERING CORPORATION (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2008046573-A1 | SUBSTITUTED SULFONAMIDE DERIVATIVES FOR USE AS BRADYKININ 1 RECEPTOR MODULATORS | Grünenthal GmbH (DE) | 2008-04-24 | — | — | WO | disclosed |
| EP-1463716-B1 | PYRROLIDINE AND PIPERIDINE DERIVATES AS NK1 ANTAGONISTS | SCHERING CORP (US) | 2008-02-13 | — | — | EP | disclosed |
| EP-1326856-B1 | PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-BETA) INHIBITING ACTIVITY | BAYER HEALTHCARE AG (DE) | 2007-12-19 | — | — | EP | disclosed |
| WO-2007056469-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | CYTOKINETICS, INC. (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2005121130-A2 | CHEMICAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2005-12-22 | — | — | WO | disclosed |